The FDA did introduce its Critical Path initiative in 2004. But, even these expedited processes have become bogged down. The FDA has responded to the political winds and become cautious after the negative publicity it received from the withdrawals of drugs like Rezulin and Vioxx. The best and most recent delay in the prostate cancer [...]
On June 27, 2009, Gina Kolata’s article in the New York Times on the too safe nature of funding from the National Institute of Health (NIH) struck a chord for many of us. She opens the article with the following, “Among the recent research grants awarded by the National Cancer Institute is one for a [...]
Please take a few minutes to help elevate OUR prostate cancer nonprofit, Malecare. As you know, Malecare started and facilitate this blog as part of our program addressing the needs of men living with advanced prostate cancer. Though Malecare is known as our country's leading gay men's cancer support group nonprofit, we are committed to [...]
Senator Arlen Specter (D-PA) introduced S. 914, the Cures Acceleration Network and National Institutes of Health Reauthorization Act of 2009. The bill has three main components: 1. Establishes a new, independent federal agency, to be known as the “Cures Acceleration Network” (CAN), which would award grants and contracts to accelerate the development of cures and [...]
Why do we need an Office of Men’s Health and why do we need more emphasize put on men’s health awareness? Studies like this one in the UK answer these simple questions: A recent study published this week by the National Cancer Intelligence Network (NCIN) and Cancer Research UK, concluded that men are almost 40 [...]